PAI Pharma
Edward Fennessy is an experienced professional in quality management within the pharmaceutical and biotechnology sectors. Currently serving as the Vice President of Quality at PAI Pharma since May 2025, Edward oversees Quality Control, Validation, Training, Quality Assurance, Labeling, and Quality Systems for liquid oral solutions. Previously, Edward held positions such as Director of Quality at Regeneron, Site Director of Quality and Regulatory Affairs at Mallinckrodt Pharmaceuticals, and President/Owner of Maide Incorporated, emphasizing quality assurance, regulatory affairs, and business development. Edward's extensive background includes roles at Johnson & Johnson and Pfizer Pharmaceuticals, where responsibilities ranged from quality operations to managing quality investigations. Edward holds a Master of Science in Chemistry from The State University of New York, a Bachelor of Science in Analytical Chemistry from the State University of New York at Fredonia, and an Associate of Science in Electrical Engineering from Cayuga Community College.
This person is not in any teams
This person is not in any offices
PAI Pharma
PAI Pharma is the industry leader of high-quality, US-made liquid and unit-dose medications. For over 50 years, PAI Pharma has produced and distributed suspensions, oral solutions, elixirs, syrups, liquids, and semi-solids. To meet the unique needs of retail chains, independent pharmacies, hospitals, long-term care facilities, and government agencies, we offer standard bottle packaging and ready-to-dispense unit-dose cups. Our mission is to participate in the creation of healthier lives by exceeding the expectations of those we serve. We do this by being the ultimate partner of choice—consistently, reliably, affordably deliver the medication the patient needs, every time.